We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+21.9%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$57.6B
AUM Growth
+$7.69B
(+15%)
Cap. Flow
+$3.7B
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
40.22%
Holding
1,054
New
202
Increased
277
Reduced
473
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$3.4B |
| 2 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$885M |
| 3 |
Tesla
TSLA
|
+$252M |
| 4 |
Amazon
AMZN
|
+$156M |
| 5 |
CLVT.PRA
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$379M |
| 2 |
Sherwin-Williams
SHW
|
+$161M |
| 3 |
NVIDIA
NVDA
|
+$154M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$116M |
| 5 |
Boeing
BA
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Consumer Discretionary | 15.59% |
| 3 | Communication Services | 15.36% |
| 4 | Healthcare | 13.38% |
| 5 | Financials | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
C.H. Robinson
CHRW
$17.3B
| $12K | ﹤0.01% |
+120
| New | +$11.8K |
|
752
Cleveland-Cliffs
CLF
$7.13B
| $12K | ﹤0.01% |
+644
| New | +$12.8K |
|
753
Delta Air Lines
DAL
$58.7B
| $12K | ﹤0.01% |
+347
| New | +$12.9K |
|
754
DT Midstream
DTM
$13.7B
| $12K | ﹤0.01% |
249
-334
| -57% | -$17.3K |
|
755
Fortune Brands Innovations
FBIN
$5.73B
| $12K | ﹤0.01% |
+200
| New | +$12.2K |
|
756
General Motors
GM
$77.2B
| $12K | ﹤0.01% |
+334
| New | +$12.6K |
|
757
Knight Transportation
KNX
$11.2B
| $12K | ﹤0.01% |
+214
| New | +$12.2K |
|
758
Landstar System
LSTR
$6.05B
| $12K | ﹤0.01% |
+68
| New | +$12K |
|
759
MKS Inc
MKSI
$19.8B
| $12K | ﹤0.01% |
+135
| New | +$12.9K |
|
760
NRG Energy
NRG
$25B
| $12K | ﹤0.01% |
355
+274
| +338% | +$9.07K |
|
761
NetApp
NTAP
$39B
| $12K | ﹤0.01% |
+190
| New | +$12.3K |
|
762
OGE Energy
OGE
$9.54B
| $12K | ﹤0.01% |
324
-936
| -74% | -$35.2K |
|
763
Omnicom Group
OMC
$23.2B
| $12K | ﹤0.01% |
123
-602
| -83% | -$53.3K |
|
764
Prudential Financial
PRU
$42.1B
| $12K | ﹤0.01% |
145
-377
| -72% | -$36K |
|
765
QuidelOrtho
QDEL
$938M
| $12K | ﹤0.01% |
+135
| New | +$11.7K |
|
766
Royalty Pharma
RPRX
$25.8B
| $12K | ﹤0.01% |
+335
| New | +$12.4K |
|
767
Schneider National
SNDR
$6.18B
| $12K | ﹤0.01% |
463
-10,618
| -96% | -$286K |
|
768
Thor Industries
THO
$4.14B
| $12K | ﹤0.01% |
147
+101
| +220% | +$8.91K |
|
769
U-Haul Holding Co
UHAL
$14.4B
| $12K | ﹤0.01% |
+193
| New | +$12.1K |
|
|
X
770
DELISTED
US Steel
X
| $12K | ﹤0.01% |
+474
| New | +$13.2K |
|
|
GAP
771
The Gap Inc
GAP
$7.74B
| $12K | ﹤0.01% |
1,190
-2,429
| -67% | -$29.6K |
|
772
Albertsons Companies
ACI
$5.89B
| $11K | ﹤0.01% |
+538
| New | +$11.1K |
|
773
Best Buy
BBY
$17.4B
| $11K | ﹤0.01% |
139
-302
| -68% | -$24.9K |
|
774
Boyd Gaming
BYD
$5.92B
| $11K | ﹤0.01% |
+174
| New | +$10.8K |
|
775
Columbia Banking Systems
COLB
$8.84B
| $11K | ﹤0.01% |
+504
| New | +$14K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2023 Portfolio in Review
As of Q1 2023, Loomis, Sayles & Company held 1,054 positions worth $57.6B, up 15% from $49.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Loomis, Sayles & Company deployed $3.7B of net new capital in Q1 2023, opening 202 new positions and adding to 277 existing holdings. Its largest new stake was Bank of America Series L: 2,835,020 shares worth $81.1M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Novartis, an estimated $379M trimmed.
- Loomis, Sayles & Company's largest Q1 2023 buy was Bank of America Series L: 2,835,020 shares worth $81.1M.
- Loomis, Sayles & Company added most to Tesla in Q1 2023, an estimated $252M increase.
- Loomis, Sayles & Company's biggest Q1 2023 reduction was Novartis, cutting an estimated $379M.
- Loomis, Sayles & Company fully exited Globus Medical in Q1 2023, selling an estimated $38M.
- Loomis, Sayles & Company's ten largest holdings make up 40% of its $57.6B portfolio in Q1 2023.
- Loomis, Sayles & Company opened 202 new positions and closed 81 in Q1 2023.
- Loomis, Sayles & Company's portfolio value rose 15% quarter-over-quarter to $57.6B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2023, filed 11 May 2023.